Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II ‐III )
Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2893|25|2|118-125
ISSN: 1352-0504
Source: JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.25, Iss.2, 2018-02, pp. : 118-125
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract